VRTX logo

VRTX
Vertex Pharmaceuticals, Inc.

12,635
Mkt Cap
$106.82B
Volume
1.17M
52W High
$519.68
52W Low
$362.50
PE Ratio
29.67
VRTX Fundamentals
Price
$422.32
Prev Close
$421.03
Open
$420.84
50D MA
$410.25
Beta
0.53
Avg. Volume
1.32M
EPS (Annual)
-$2.08
P/B
6.17
Rev/Employee
$1.8M
Loading...
Loading...
News
all
press releases
Vertex to Participate in the Citis 2025 Global Healthcare Conference on December 3
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced management participation in Citis 2025 Global Healthcare Conference. Charlie Wagner, Chief Operating and Financial Officer, and...
Business Wire·1d ago
News Placeholder
More News
News Placeholder
Promising Biotech Stocks To Consider - November 18th
Danaher, Cidara Therapeutics, argenex, Vertex Pharmaceuticals, and Arvinas are the five Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of...
MarketBeat·1d ago
News Placeholder
Jeffrey Leiden Sells 19,688 Shares of Vertex Pharmaceuticals (NASDAQ:VRTX) Stock
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Get Free Report) Chairman Jeffrey Leiden sold 19,688 shares of the business's stock in a transaction dated Thursday, November 13th. The shares were...
MarketBeat·2d ago
News Placeholder
Jeffrey Leiden Sells 53,604 Shares of Vertex Pharmaceuticals (NASDAQ:VRTX) Stock
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Get Free Report) Chairman Jeffrey Leiden sold 53,604 shares of the firm's stock in a transaction dated Friday, November 14th. The stock was sold at...
MarketBeat·2d ago
News Placeholder
Biotech Stocks To Research - November 17th
Cidara Therapeutics, Danaher, argenex, Vertex Pharmaceuticals, and Abivax are the five Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of...
MarketBeat·2d ago
News Placeholder
Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know
Vertex (VRTX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Zacks·2d ago
News Placeholder
Rockefeller Capital Management L.P. Acquires 8,736 Shares of Vertex Pharmaceuticals Incorporated $VRTX
Rockefeller Capital Management L.P. grew its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 9.6% during the second quarter, according to the company in its most recent...
MarketBeat·2d ago
News Placeholder
Intech Investment Management LLC Has $7.79 Million Stake in Vertex Pharmaceuticals Incorporated $VRTX
Intech Investment Management LLC grew its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 101.1% during the 2nd quarter, according to the company in its most recent...
MarketBeat·2d ago
News Placeholder
Biotech Stocks To Keep An Eye On - November 16th
Cidara Therapeutics, Danaher, Vertex Pharmaceuticals, argenex, and Abivax are the five Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of...
MarketBeat·3d ago
News Placeholder
Universal Beteiligungs und Servicegesellschaft mbH Purchases 7,220 Shares of Vertex Pharmaceuticals Incorporated $VRTX
Universal Beteiligungs und Servicegesellschaft mbH raised its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 2.4% in the 2nd quarter, according to its most...
MarketBeat·3d ago

Latest VRTX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.